AURO LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of AURO LABORATORIES have increased by 3.99% YoY .
The Earnings Per Share (EPS) of AURO LABORATORIES has decreased by -14.04 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
AURO LABORATORIES Last 5 Annual Financial Results
[BOM: 530233]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹53 Cr | ₹51 Cr | ₹54 Cr | ₹44 Cr | ₹47 Cr |
| Expenses | ₹49 Cr | ₹46 Cr | ₹43 Cr | ₹38 Cr | ₹40 Cr |
| Operating Profit (Excl OI) | ₹4.39 Cr | ₹4.63 Cr | ₹11 Cr | ₹6.27 Cr | ₹6.99 Cr |
| Other Income | ₹0.94 Cr | ₹1.09 Cr | ₹0.76 Cr | ₹0.97 Cr | ₹0.96 Cr |
| Interest | ₹0.81 Cr | ₹0.83 Cr | ₹0.46 Cr | ₹0.58 Cr | ₹0.87 Cr |
| Depreciation | ₹1.07 Cr | ₹1.02 Cr | ₹1.04 Cr | ₹1.02 Cr | ₹1.01 Cr |
| Profit Before Tax | ₹3.45 Cr | ₹3.87 Cr | ₹11 Cr | ₹5.64 Cr | ₹6.07 Cr |
| Profit After Tax | ₹2.44 Cr | ₹2.85 Cr | ₹7.18 Cr | ₹4.05 Cr | ₹4.40 Cr |
| Consolidated Net Profit | ₹2.44 Cr | ₹2.85 Cr | ₹7.18 Cr | ₹4.05 Cr | ₹4.40 Cr |
| Earnings Per Share (Rs) | ₹3.92 | ₹4.56 | ₹11.52 | ₹6.51 | ₹7.06 |
| PAT Margin (%) | 4.62 | 5.59 | 13.23 | 9.26 | 9.40 |
| ROE(%) | 7.43 | 9.47 | 28.67 | 20.84 | 28.95 |
| ROCE(%) | 9.92 | 12.20 | 38.88 | 24.80 | 29.12 |
| Total Debt/Equity(x) | 0.19 | 0.44 | 0.11 | 0.15 | 0.46 |
Key Financials |
||
| Market Cap | : | ₹ 113.3 Cr |
| Revenue (TTM) | : | ₹ 55.1 Cr |
| Net Profit(TTM) | : | ₹ 7.2 Cr |
| EPS (TTM) | : | ₹ 11.6 |
| P/E (TTM) | : | 15.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AURO LABORATORIES | 6% | -9.2% | 179.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
AURO LABORATORIES Revenues
[BOM: 530233]
| Y-o-Y | 3.99 % |
| 5 Yr CAGR | 3.09 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹53 Cr | 3.99 | |
| Mar2022 | ₹51 Cr | -6.24 | |
| Mar2021 | ₹54 Cr | 23.89 | |
| Mar2020 | ₹44 Cr | -6.48 | |
| Mar2019 | ₹47 Cr | - | |
AURO LABORATORIES Operating Profit
[BOM: 530233]
| Y-o-Y | -5.02 % |
| 5 Yr CAGR | -10.97 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹4.39 Cr | -5.02 | |
| Mar2022 | ₹4.63 Cr | -58.86 | |
| Mar2021 | ₹11 Cr | 79.30 | |
| Mar2020 | ₹6.27 Cr | -10.34 | |
| Mar2019 | ₹6.99 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -8.58 % |
| 5 Yr CAGR | -13.63 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 8.31% | -8.58 | |
| Mar2022 | 9.09% | -56.13 | |
| Mar2021 | 20.72% | 44.69 | |
| Mar2020 | 14.32% | -4.09 | |
| Mar2019 | 14.93% | - | |
AURO LABORATORIES Profit After Tax
[BOM: 530233]
| Y-o-Y | -14.17 % |
| 5 Yr CAGR | -13.68 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹2.44 Cr | -14.17 | |
| Mar2022 | ₹2.85 Cr | -60.38 | |
| Mar2021 | ₹7.18 Cr | 77.11 | |
| Mar2020 | ₹4.05 Cr | -7.84 | |
| Mar2019 | ₹4.40 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -17.35 % |
| 5 Yr CAGR | -16.27 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 4.62 % | -17.35 | |
| Mar2022 | 5.59 % | -57.75 | |
| Mar2021 | 13.23 % | 42.87 | |
| Mar2020 | 9.26 % | -1.49 | |
| Mar2019 | 9.4 % | - | |
AURO LABORATORIES Earnings Per Share (EPS)
[BOM: 530233]
| Y-o-Y | -14.04 % |
| 5 Yr CAGR | -13.68 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹3.92 | -14.04 | |
| Mar2022 | ₹4.56 | -60.42 | |
| Mar2021 | ₹12 | 76.96 | |
| Mar2020 | ₹6.51 | -7.79 | |
| Mar2019 | ₹7.06 | - | |
AURO LABORATORIES Return on Capital Employed (ROCE)
[BOM: 530233]
| Y-o-Y | -18.69 % |
| 5 Yr CAGR | -23.60 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 9.92% | -18.69 | |
| Mar2022 | 12.2% | -68.62 | |
| Mar2021 | 38.88% | 56.77 | |
| Mar2020 | 24.8% | -14.84 | |
| Mar2019 | 29.12% | - | |
AURO LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹182.8 |
| Current MarketCap | : | ₹ 113.3 Cr |
| Updated EOD on | : | Apr 16,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AURO LABORATORIES | 6% |
-9.2% |
179.9% |
| SENSEX | -2.4% |
-1% |
21.3% |
AURO LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about AURO LABORATORIES Financials
How the annual revenues of AURO LABORATORIES have changed ?
The Revenues of AURO LABORATORIES have increased by 3.99% YoY .
How the Earnings per Share (EPS) of AURO LABORATORIES have changed?
The Earnings Per Share (EPS) of AURO LABORATORIES has decreased by -14.04 % YoY .
Check out Intrinsic Value of Peers of AURO LABORATORIES
Compare Stock Analytics of Peers of AURO LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
